Subscribe To
Agarwood essential oil market worth usd 345.5 million by 2030 at 6.35% cagr – report by market research future (mrfr)
Agarwood Essential Oil Market: Information by Type (Compound Essential Oil, Pure Essential Oil), Raw Material (Woods, Resin, Bark, and Flowers) Applic...
January 30, 2023, 2:48 pm
Amgen layoffs 2023: what to know about the latest amgn job cuts
Biopharmaceutical company Amgen (NASDAQ: AMGN ) announced this morning it has laid off about 300 U.S. e...
January 30, 2023, 2:34 pm
Evoke announces teva ends pursuit of paragraph iv anda against gimoti
Stipulation of Dismissal of Claims, Defenses and Counterclaims for Patent Infringement Case Filed SOLANA BEACH, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE)...
January 30, 2023, 12:00 pm
C4 therapeutics announces first patient dosed in phase 1/2 clinical trial evaluating cft1946, an orally bioavailable bidac™ degrader, in braf v600 mutant solid tumors
WATERTOWN, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage bio...
January 30, 2023, 12:00 pm
First wave biopharma to present at the bio ceo & investor conference
BOCA RATON, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a cli...
January 30, 2023, 12:00 pm
Tonix pharmaceuticals regains compliance with nasdaq minimum bid price requirement
CHATHAM, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) — Tonix pharmaceuticals Holding Corp. (Nasdaq: TNXP) (T...
January 30, 2023, 12:00 pm
Beyond cancer® appoints gavin choy, pharmd as chief operating officer
Dr. Choy brings more than 20+ years of pharmaceutical and biotechnology operating experience to Beyond ...
January 30, 2023, 12:00 pm
Cardinal health (cah) to post q2 earnings: what's in store?
Cardinal Health's (CAH) second-quarter fiscal 2023 results are likely to reflect solid performance in the phar...
January 30, 2023, 9:47 am
Cyclacel pharmaceuticals to participate in the 2023 bio ceo & investor conference
BERKELEY HEIGHTS, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cyclacel pharmaceuticals, Inc. (NASDAQ: CYCC,...
January 30, 2023, 9:15 am
Fsd pharma says recruiting underway in phase 2 trial of fsd201 for treating chronic pain associated with idiopathic mcas
FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) said recruiting is underway for the Phase 2 clinical trial of FSD-PEA (FSD201) for the treatment of chronic p...
January 30, 2023, 9:09 am
3 momentum anomaly stocks to buy as q4 gdp instills confidence
World Wrestling Entertainment (WWE), Dycom (DY) and Catalyst pharmaceuticals (CPRX) are currently witne...
January 30, 2023, 9:02 am
First wave biopharma to present at the bio ceo & investor conference
BOCA RATON, Fla., Jan. 30, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clin...
January 30, 2023, 7:00 am
Structure therapeutics sets ipo terms, to be valued at up to $522 million
Structure Therapeutics Inc. has set terms for its initial public offering (IPO), as the California-based bioph...
January 30, 2023, 6:45 am
Ge healthcare reports first results after ge spinoff, with revenue rising 8% but profit slipping
Shares of GE HealthCare GEHC, slipped 0.1% in premarket trading Monday, after the medical technology and pharm...
January 30, 2023, 6:39 am
Opthea to present at sequire biotechnology conference
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage bio...
January 30, 2023, 6:00 am
Veeva systems: a leading provider of cloud-based solutions for the pharmaceutical industry
Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences indu...
January 29, 2023, 10:35 pm
Why shares of phathom pharmaceutical jumped this week
Investors are reading between the lines to see if the company is fixing its problems regarding its lead therapy....
January 28, 2023, 1:58 pm
Achieve life sciences announces granting of new hire inducement award
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage ...
January 27, 2023, 9:30 pm
Avenue therapeutics announces $3.25 million registered direct and private placement priced at the market under nasdaq rules
MIAMI, Jan. 27, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty ...
January 27, 2023, 4:58 pm
Anebulo: interesting drug for cannabis intoxication, but the market potential remains unclear
Anebulo pharmaceutical is a US small-cap ($80M market cap) biotech company that is developing a phase 2...
January 27, 2023, 3:49 pm